Nucl Med Mol Imaging.  2022 Aug;56(4):211-217. 10.1007/s13139-022-00749-3.

Technetium 99m PSMA Superscan Mimicking a Bone Scan Gone Wrong

Affiliations
  • 1Department of Nuclear Medicine, University of The Free State, Bloemfontein, South Africa
  • 2Department of Radiation Oncology, University of The Free State, Bloemfontein, South Africa

Abstract

Imaging of metastatic castrate-resistant prostate cancer to select patients suitable for peptide receptor radioligand therapy can be performed with both SPECT and PET PSMA radiotracers. Although PET radiotracers generally have higher sensitivity and spatial resolution, SPECT tracers can be an effective alternative when PET/CT systems are unavailable in the clinical setting. We present a case of a 43-year-old male, who was referred to our facility for workup for radioligand PSMA therapy. His Tc-99m PSMA images revealed diffuse bone infiltration in a pattern mimicking a bone scan.

Keyword

Prostate cancer; Tc-99m PSMA; SPECT/CT; PET/CT
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr